Table 1 Differences between matched and unmatched cohort of DR-TB patients initiated on antiretroviral therapy
All DR-TB/ART patients (n = 3105) | Not matched to ART data (n = 1167) | Matched to ART data (n = 1938) | |
|---|---|---|---|
Site, n (%) | |||
Site 1 (FIS/TE) | 186 (6.0%) | 37 (3.2%) | 149 (7.7%) |
Site 2 (EDRWeb/TIER.NET) | 449 (14.5%) | 109 (9.4%) | 340 (17.5%) |
Site 3 (EDRWeb/TIER.NET) | 2470 (79.5%) | 1021 (87.5%) | 1449 (74.8%) |
Gender, n (%) | |||
Female | 1615 (52.1%) | 614 (52.7%) | 1001 (51.7%) |
Male | 1489 (48.0%) | 553 (47.4%) | 936 (48.3%) |
Age, median (IQR) | 35 (29–41) | 35 (30–41) | 34 (29–41) |
Patient category | |||
New | 1196 (38.5%) | 430 (36.8%) | 766 (39.5%) |
Treatment after failure | 1201 (38.7%) | 465 (39.8%) | 736 (38.0%) |
Relapse | 495 (15.9%) | 198 (17.0%) | 297 (15.3%) |
Treatment after loss to follow-up | 183 (5.9%) | 64 (5.5%) | 119 (6.1%) |
Transfer-in | 1 (< 0.1%) | 1 (0.1%) | 0 (0.0%) |
Other | 7 (0.2%) | 4 (0.3%) | 3 (0.2%) |
Unknown | 22 (0.7%) | 5 (0.4%) | 17 (0.9%) |
TB type | |||
Extra-pulmonary TB | 82 (2.6%) | 21 (1.7%) | 61 (3.1%) |
Pulmonary TB | 2672 (86.1%) | 1045 (89.6%) | 1627 (84.0%) |
Missing | 351 (11.3%) | 101 (8.7%) | 250 (12.9%) |
TB outcome | |||
Cure | 1038 (33.4%) | 431 (36.9%) | 607 (31.3%) |
Completed treatment | 661 (21.3%) | 210 (18.0%) | 451 (23.3%) |
Death | 557 (17.9%) | 208 (17.8%) | 349 (18.0%) |
Treatment failure | 72 (2.3%) | 19 (1.6%) | 53 (2.7%) |
Lost to follow-up | 689 (22.2%) | 276 (23.7%) | 413 (21.3%) |
Transferred out | 30 (1.0%) | 13 (1.1%) | 17 (0.9%) |
Still on treatment | 17 (0.5%) | 2 (0.2%) | 15 (0.8%) |
Other | 1 (0.0%) | 0 (0.0%) | 1 (0.1%) |
Not specified | 27 (0.9%) | 3 (0.3%) | 24 (1.2%) |